Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01372345 · ClinicalTrials.gov registry record · Phase 1

Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Fasting Conditions

A Phase 1 study of Fasting, sponsored by Dr. Reddy's Laboratories Limited.

Completed
Registry status
Phase 1
Development phase
43
Enrollment target
1
Study location

NCT01372345 is a Phase 1 study of Fasting that has completed, run by Dr. Reddy's Laboratories Limited. The registered enrollment target is 43 participants, below the 204-participant average among 8 other Fasting trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01372345, a Phase 1 study of Fasting, has completed, sponsored by Dr. Reddy's Laboratories Limited.

COMPLETED
Registry status
Phase 1
Development phase
43 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the relative bioavailability of ciprofloxacin 1000 mg ER tablets of Dr.Reddy's with that of CIPRO® XR 1000 mg of Bayer Pharmaceuticals Corporation in healthy, adult, non-smoking subjects under fasting conditions.

Conditions Studied

Interventions

  • DRUG CIPRO®XR

Study Locations (1)

Texas

  • NOVUM Pharmaceutical Research Services - Houston

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2005-02
Est. Completion 2005-03
Phase Phase 1

Sponsor

Dr. Reddy's Laboratories Limited

52 total trials

What the Registry Record Tells You About NCT01372345

The ClinicalTrials.gov registry entry for NCT01372345 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 204-participant average among 8 other Fasting trials with a reported enrollment target (79% lower). The listed sponsor is Dr. Reddy's Laboratories Limited, which has 52 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Fasting appearing as the primary indexed condition, and to 1 intervention - of which CIPRO®XR is the first listed.

NCT01372345 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT01372345 about?

NCT01372345 is a clinical study titled "Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Fasting Conditions". The purpose of this study is to compare the relative bioavailability of ciprofloxacin 1000 mg ER tablets of Dr.Reddy's with that of CIPRO® XR 1000 mg of Bayer Pharmaceuticals Corporation in healthy, adult, non-smoking subjects under fasting conditions.

What is the current status of trial NCT01372345?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 43 participants. The study started on 2005-02. Estimated completion is 2005-03.

What conditions does trial NCT01372345 study?

This clinical trial studies the following conditions: Fasting.

What interventions are being tested in trial NCT01372345?

The interventions under investigation include: CIPRO®XR (DRUG).

Who is sponsoring clinical trial NCT01372345?

This trial is sponsored by Dr. Reddy's Laboratories Limited, which has 52 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01372345 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fasting

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.